" /> Acalabrutinib/Obinutuzumab/Venetoclax Regimen - CISMeF





Preferred Label : Acalabrutinib/Obinutuzumab/Venetoclax Regimen;

NCIt synonyms : Acalabrutinib-Obinutuzumab-Venetoclax; Acalabrutinib/Obinutuzumab/Venetoclax; Obinutuzumab/Venetoclax/Acalabrutinib; Calquence/Gazyva/Venclexta Regimen; Venetoclax/Acalabrutinib/Obinutuzumab; Acalabrutinib/Venetoclax/Obinutuzumab; Venetoclax/Obinutuzumab/Acalabrutinib; Venclexta/Calquence/Gazyva; Obinutuzumab/Acalabrutinib/Venetoclax;

NCIt definition : A regimen consisting of acalabrutinib, obinutuzumab and venetoclax that can be used for the treatment of chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL).;

Détails


Position du mot-clé dans l'(les) arborescence(s) : arborescence

Vous pouvez consulter :


Nous contacter.
28/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.